If side effects are severe or persistent beyond the first few weeks, your GP or diabetes specialist may suggest: Temporary dose reduction Anti-emetic medication for nausea Review of concomitant diabetes medications to reduce hypoglycaemia risk Alternative GLP-1 receptor agonist formulations if oral semaglutide remains poorly tolerated According to NICE guidelines (NG28) , treatment decisions should be individualised based on efficacy, tolerability, patient preference, and cost-effectiveness
Approximately one-third of the patients had temporary gastrointestinal side effects
Giorgino, GLP-1 receptor agonists for cardiovascular protection: a matter of time
Adverse reactions are rare
MBS720260) (MyBioSource, San Diego, CA), and interleukin-6 (IL-6) (cat no
If your insurance is in-network, you may qualify for Founds Insurance Plus plan ($39/month or $199/year)